5th Heart in Diabetes (HiD) 

Dates: June 18-20, 2021

Grand Hyatt, New York City


Abstract Submission Deadline: May 14, 2021
 

  •  Accepted Abstracts will be published in American Heart Journal, Editor-in-Chief: Daniel Mark, MD, MPH 
  • Accepted Abstracts will have poster presentation at the meeting.
  • Top Abstracts will be selected for oral presentation at the meeting.
  • In some cases, the committee may consider Late Breaking Abstracts for oral presentation. 
  •  Top 4 Abstracts will receive awards and cash prizes.

 
Late Breaking Submission will be open from May 24 - June 4, 2021

***Please note,  if an author wishes to make changes or withdraw their abstract, they must contact the HiD team no later than June 11, 2021. HiD cannot guarantee that any change or withdraw requests submitted after this date will be accommodated. All requests should be submitted via e-mail to info@tmioa.com
 
Abstract Submission Topics
Abstracts should address state-of-the-art clinical research aspects of diabetes and the heart. (As an example, obesity by itself will NOT qualify, but obesity as it relates to diabetes and/or cardiovascular disease will qualify).

Topics include: diabetes, hypoglycemia, prediabetes, and/or cardiometabolic syndrome, retinopathy, obesity, neuropathy, dyslipidemia, triglycerides, cholesterol, hypertension, congestive heart failure (CHF), atherosclerosis, cardiovascular disease, arrhythmia, kidney/renal disease, cardiorenal syndrome, thrombosis, coagulation abnormalities, therapeutics, clinical trials, cardiovascular outcome trials, epidemiology, fatty liver, inflammation, guidelines on practice, technology, peripheral vascular disease, and related conditions

Although the posters are not designed for basic science, abstracts which consider unknown MOA (mode of action) of medications or pathophysiology of related medical conditions may be accepted.


Abstract Poster Presentations

Abstracts may be submitted for poster presentation. If selected for poster presentation, the author(s) or presenter(s) are required to register for the Congress and to be present during the poster sessions. The presenter in attendance must be one of the authors listed on the abstract. Poster Presentation Session Time and Date TBA.
 ​
Abstract Oral Presentations
Four of the highest-ranking abstracts will be selected for the Abstract Oral Presentation Session - Time and Date TBA  (once ready, 5th HiD agenda may be viewed at www.heartindiabetes.com/agenda). In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by a 5 minute period of Q&A. If selected, an author is required to register to the meeting and to be prepared with a PowerPoint presentation. Oral presenters who have an interest or involvement in selling a technology, program, product, and/or service to healthcare professionals must submit an official disclosure document in order to be considered for and to present their work at the abstract oral session.
 ​
Top Abstract Awards
Awards will be given to the highest ranking abstracts. The award levels are: Gold, Silver, Bronze and honorable mention.
 ​
In addition:
 

  • Scientific materials presented at the 5th Annual Heart in Diabetes (2021) must not have been published or presented prior to June 18, 2021 other than in abstract form.
  • All abstracts must be submitted electronically and should be no more than 250 words (Titles, author(s) names, and affiliations are not included in the word count).
  •  Graphs or figures submitted must be in TIFF or JPG format. 
  • All materials must arrive on or before the abstract deadline noted above.
  • Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.
  • Authorship on multiple abstracts is permitted.
  • All submitted content will be graded by the 2021 Heart in Diabetes Scientific Abstract Committee.
  •  Abstracts will be published in an issue of American Heart Journal TBD.

 

Deadline to Submit Abstracts: October 26, 2020

  • All accepted Abstracts will be published in Metabolism,      Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult
  • Accepted Abstracts will have virtual poster presentation.
  • Top Abstracts will be selected for oral presentation on the      virtual platform
  • In some cases, the committee may consider Late Breaking Abstracts      for oral presentation.
  • Top 4 Abstracts will receive awards and cash prizes

***Please note,  if an author wishes to make changes or withdrawal their abstract, they must contact the WCIRDC team no later than November 13, 2020. WCIRDC cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. All requests should be submitted via e-mail to info@tmioa.com 

Late Breaking Abstract Submission will be open from November 2 - 16, 2020.

Abstract Submission & Topics: Clinical aspects of insulin resistance in childhood, adolescence and/or adulthood pertaining to: Diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal disease, gonadal dysfunction, sleep disorders such as obstructive sleep apnea 

Basic science: Mechanisms of insulin resistance, inflammation, endothelial and vascular dysfunction, metabolic dysfunction of centers such as the beta cell, adipocyte, gut, and brain 

Abstract Guidelines: Abstracts should address either clinical or basic science aspects of insulin resistance, in fields such as diabetes, obesity, and cardiovascular disease. Investigations of overall pathophysiology and/or effects on key metabolic centers such as the beta cell, adipocyte, gut, and brain would be of interest, as would be studies of inflammation and of endothelial or other vascular dysfunction. Clinical topics may include any aspect of insulin resistance in childhood, adolescence and/or adulthood in relationship to the causation and/or natural history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction (including both PCOS and male hypogonadism), gestational diabetes, other endocrine abnormality, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.

The interests of the Congress include multi-hormonal aspects of obesity, incretins and other gut hormonal contributions to energy balance, and circadian rhythm as it relates to these metabolic mechanisms. Basic science studies should include those with specific relationship to insulin action and its regulation at the cellular, organ, or whole body level. To demonstrate their conformity to this guideline, authors are encouraged to include a brief clarification of the relationship of their topic to insulin resistance and/or to the above metabolic processes.

Abstract Poster Presentations

Accepted abstracts may be submitted for a virtual poster presentation. If selected for virtual poster presentation, the author or presenter is required to register for the Congress. 

Abstract Oral Presentations

4 of the highest-ranking abstracts will be selected for the Abstract Oral Presentation Session – for Time and Date please visit wcir.org/agenda. In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by a 5 minute period of Q&A. If selected, an author is required to register to the meeting and to be prepared with a PowerPoint presentation. WCIRDC team will notify oral presenters about the prerecording presentation.

Top Abstract Awards Awards will be given to the highest ranking abstracts. The award levels are: Gold, Silver, Bronze and honorable mentions and are chosen from the Abstract Oral Winners. 

In addition:

  • Scientific materials presented at the 18th Annual World Congress on Insulin      Resistance, Diabetes and Cardiovascular Disease (2019) must not have been      published or presented prior to December 3, 2020, other than in abstract      form.
  • All abstracts must be submitted electronically and be no more than 250      words
  • Abstracts should NOT include any tables, graphs, figures or references
  • All materials must arrive on or before the abstract deadline noted.
  • Notification of acceptance will be e-mailed as soon as the committee accepts the      abstract.
  • Authorship on multiple abstracts is permitted.
  • All submitted materials will be graded by the scientific planning committee,      The International Committee for Insulin Resistance.
  • Abstracts will be published in Metabolism,      Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult

Poster Guidelines: Authors are welcome to create and submit a digital poster in PDF format to be displayed on the 18th WCIRDC Virtual Platform. View more on guidelines at https://www.wcir.org/abstract-guidelines